Table 2.

Data from the validation cohort of patients.

pathological grade/stage	NMIBC	NMIBC	MIBC	T0G0
	Ta G1–G2 low grade	T1 G1–G2 high grade	T2–T4 high grade
	(n = 17)	(n = 16)	(n = 17)	(n = 15)
Mean age ± SD	59.2 ± 10.4	73.5 ± 11.6	72.1 ± 9.3	65.3 ± 12.2
Gender (%)
male	14 (82)	14 (87,5)	15 (88)	12 (80)
female	3 (18)	2 (12,5)	2 (12)	3 (20)
Carcinoma in situ (CIS) (%)
Yes	0	1 (6)	3 (18)	0
No	17 (100)	15 (94)	14 (82)	15 (100)
First episode (%)
Yes	15 (88)	7 (44)	7 (41)	1 (7)
No	2 (12)	9 (56)	10 (59)	14 (93)
Smoking (%)
Ever	12 (71)	10 (62)	11 (65)	10 (67)
Never	5 (29)	6 (38)	7 (35)	5 (33)

NMIBC, Non-Muscle Invasive Bladder Cancer; MIBC, Muscle-Invasive Bladder Cancer; T0G0, No tumor detected at the histological evaluation.